{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:19:57Z","timestamp":1787566797995,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.eclinm.2026.104111","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:34:54Z","timestamp":1784820894000},"page":"104111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Potential preventive role of low-dose methotrexate against incident recorded psychosis: a retrospective cohort study based on electronic health records"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9202-3987","authenticated-orcid":false,"given":"Fabiana","family":"Corsi-Zuelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Taquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Deakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8204-5103","authenticated-orcid":false,"given":"Rachel","family":"Upthegrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2026.104111_bib1","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jamapsychiatry.2025.1369","article-title":"Current position and future direction of inflammation in neuropsychiatric disorders: a review","volume":"82","author":"Upthegrove","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.eclinm.2026.104111_bib2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","article-title":"Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis","volume":"10","author":"Halstead","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.eclinm.2026.104111_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41398-020-01095-8","article-title":"A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis","volume":"10","author":"Chaudhry","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.eclinm.2026.104111_bib4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/acr.24596","article-title":"2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.eclinm.2026.104111_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaut.2018.01.004","article-title":"TGF-\u03b2 signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis","volume":"90","author":"Peres","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.eclinm.2026.104111_bib6","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.1424792112","article-title":"Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis","volume":"112","author":"Peres","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.eclinm.2026.104111_bib7","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.39031","article-title":"Methotrexate restores regulatory T cell function through demethylation of the FoxP3 upstream enhancer in patients with rheumatoid arthritis","volume":"67","author":"Cribbs","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.eclinm.2026.104111_bib8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cell.2020.06.026","article-title":"Microglia require CD4 T cells to complete the fetal-to-adult transition","volume":"182","author":"Pasciuto","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.eclinm.2026.104111_bib9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neubiorev.2021.03.004","article-title":"Impaired regulatory T cell control of astroglial overdrive and microglial pruning in schizophrenia","volume":"125","author":"Corsi-Zuelli","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.eclinm.2026.104111_bib10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1192\/bjp.bp.111.092098","article-title":"Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study","volume":"200","author":"Chen","year":"2012","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.eclinm.2026.104111_bib11","article-title":"Assessing whether the association between rheumatoid arthritis and schizophrenia is bidirectional: a nationwide population-based cohort study","volume":"9","author":"Chen","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.eclinm.2026.104111_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biopsych.2018.06.016","article-title":"Associations between non-neurological autoimmune disorders and psychosis: a meta-analysis","volume":"85","author":"Cullen","year":"2019","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.eclinm.2026.104111_bib13","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/schbul\/sbu054","article-title":"The association between schizophrenia and rheumatoid arthritis: a nationwide population-based swedish study on intraindividual and familial risks","volume":"40","author":"Sellgren","year":"2014","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.eclinm.2026.104111_bib14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jpsychires.2025.03.020","article-title":"Beyond rheumatoid arthritis: a meta-analysis of the prevalence of anxiety and depressive disorders in rheumatoid arthritis","volume":"184","author":"Drakes","year":"2025","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.eclinm.2026.104111_bib15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jad.2022.05.108","article-title":"Elucidating a bidirectional association between rheumatoid arthritis and depression: a systematic review and meta-analysis","volume":"311","author":"Ng","year":"2022","journal-title":"J Affect Disord"},{"key":"10.1016\/j.eclinm.2026.104111_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjment-2025-301706","article-title":"Affective disorders and chronic inflammatory conditions: analysis of 1.5 million participants in our future health","volume":"28","author":"Mudra Rakshasa-Loots","year":"2025","journal-title":"BMJ Mental Health"},{"key":"10.1016\/j.eclinm.2026.104111_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jamapsychiatry.2017.3554","article-title":"Treated incidence of psychotic disorders in the multinational EU-GEI study","volume":"75","author":"Jongsma","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.eclinm.2026.104111_bib18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1756-185X.2010.01564.x","article-title":"Low-dose and high-dose methotrexate are two different drugs in practical terms","volume":"13","author":"Malaviya","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.eclinm.2026.104111_bib19","first-page":"353","volume":"2","author":"Shah","year":"2021"},{"key":"10.1016\/j.eclinm.2026.104111_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0165-0327(83)90022-8","article-title":"Steroid-induced psychiatric syndromes: a report of 14 cases and a review of the literature","volume":"5","author":"Lewis","year":"1983","journal-title":"J Affect Disord"},{"key":"10.1016\/j.eclinm.2026.104111_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-13-152","article-title":"Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome","volume":"13","author":"Royston","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.eclinm.2026.104111_bib22","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1038\/s41591-024-03201-5","article-title":"The recombinant shingles vaccine is associated with lower risk of dementia","volume":"30","author":"Taquet","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.eclinm.2026.104111_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102726","article-title":"12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study","volume":"74","author":"De Giorgi","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.eclinm.2026.104111_bib24","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/1536867X1601600310","article-title":"strmst2 and strmst2pw: new commands to compare survival curves using the restricted mean survival time","volume":"16","author":"Cronin","year":"2016","journal-title":"Stata J"},{"key":"10.1016\/j.eclinm.2026.104111_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152031","article-title":"Methotrexate use reduces mortality risk in rheumatoid arthritis: a systematic review and meta-analysis of cohort studies","volume":"55","author":"Xu","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.eclinm.2026.104111_bib26","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1007\/s10787-025-01908-6","article-title":"Efficacy and safety of celecoxib in schizophrenia: a systematic review and meta-analysis of randomized controlled trials","volume":"33","author":"Farag","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.eclinm.2026.104111_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000542-200502000-00026","article-title":"Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans","volume":"102","author":"Dembo","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.eclinm.2026.104111_bib28","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1074\/jbc.272.6.3406","article-title":"Peroxisome proliferator-activated receptors \u03b1 and \u03b3 are activated by indomethacin and other non-steroidal anti-inflammatory drugs","volume":"272","author":"Lehmann","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.eclinm.2026.104111_bib29","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/sj.bjc.6604049","article-title":"Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy","volume":"97","author":"Sch\u00f6nthal","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eclinm.2026.104111_bib30","article-title":"T regulatory cells as a potential therapeutic target in psychosis? Current challenges and future perspectives","volume":"17","author":"Corsi-Zuelli","year":"2021","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.eclinm.2026.104111_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.schres.2025.07.022","article-title":"Low-dose methotrexate as a potential treatment for schizophrenia via astrocytic and neuroimmune modulation","volume":"284","author":"Lima","year":"2025","journal-title":"Schizophr Res"},{"key":"10.1016\/j.eclinm.2026.104111_bib32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41577-023-00960-z","article-title":"Brain regulatory T cells","volume":"24","author":"Liston","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.eclinm.2026.104111_bib33","first-page":"1","article-title":"Global, regional, and national epidemiology of rheumatoid arthritis among people aged 20\u201354 years from 1990 to 2021","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.eclinm.2026.104111_bib34","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1136\/rmdopen-2023-003038","article-title":"COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs","volume":"9","author":"Tsai","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.eclinm.2026.104111_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/pds.70198","article-title":"TriNetX Dataworks-USA: overview of a multi-purpose, de-identified, federated electronic health record real-world data and analytics network and comparison to the US census","volume":"34","author":"Stein","year":"2025","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:28:34Z","timestamp":1787560114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026003640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"alternative-id":["S2589537026003640"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104111","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential preventive role of low-dose methotrexate against incident recorded psychosis: a retrospective cohort study based on electronic health records","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104111"}}